C-peptide as a risk factor of coronary artery disease in the general population

Diabetes and Vascular Disease Research

Volumn 12, Issue 3, 2015, Pages 199-207

  Cabrera De León, Antonio ^a,b,c   Oliva García, José Gregorio ^a   Marcelino Rodríguez, Itahisa ^a,c   Almeida González, Delia ^a,c   Alemán Sánchez, José Juan ^a,c   Brito Díaz, Buenaventura ^a,c   Domínguez Coello, Santiago ^a,c   Bertomeu Martínez, Vicente ^c,d   Aguirre Jaime, Armando ^a   Rodríguez Pérez, María Del Cristo ^a,c  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

C peptide; coronary artery disease; insulin resistance; risk factor

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK ASSESSMENT; ADOLESCENT; BLOOD; CHI SQUARE DISTRIBUTION; EARLY DIAGNOSIS; INCIDENCE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SPAIN; UPREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; C-PEPTIDE; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SPAIN; UP-REGULATION; YOUNG ADULT;

EID: 84926429311     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164114564900     Document Type: Article

References (28)

1. Steiner DF, Cunningham D, Spigelman L, et al. Insulin biosynthesis: evidence for a precursor. Science. 1967 ; 157: 697-700
2. Wahren J, Shafqat J, Johansson J, et al. Molecular and cellular effects of C-peptide - new perspectives on an old peptide. Exp Diabesity Res. 2004 ; 5: 15-23
3. Marx N, Walcher D. C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus?. Exp Diabetes Res. 2008 ; 2008: 385108
4. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002 ; 287: 2570-2581
5. Marx N. C-peptide as a mediator of lesion development in early diabetes - a novel hypothesis. Trends Cardiovasc Med. 2008 ; 18: 67-71
6. Marx N, Walcher D, Raichle C, et al. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol. 2004 ; 24: 540-545
7. Al-Rasheed NM, Chana RS, Baines RJ, et al. Ligand independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity. J Biol Chem. 2004 ; 26: 49747-49754
8. Walcher D, Babiak C, Poletek P, et al. C-peptide induces vascular smooth muscle cell proliferation: involvement of Src-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res. 2006 ; 99: 1181-1187
9. Bo S, Gentile L, Castiglione A, et al. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol. 2012 ; 167: 173-180
10. Hirai FE, Moss SE, Klein BE, et al. Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care. 2008 ; 31: 493-497
11. Kim ST, Kim BJ, Lim DM, et al. Basal C-peptide level as a surrogate marker of subclinical atherosclerosis in type 2 diabetic patients. Diabetes Metab J. 2011 ; 35: 41-49
12. Marx N, Silbernagel G, Brandenburg V, et al. C-Peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC Study. Diabetes Care. 2013 ; 36: 708-714
13. Cabrera de León A, Rodríguez Pérez MC, Almeida González D, et al. Presentation of the 'CDC de Canarias' cohort: objectives, design and preliminary results. Rev Esp Salud Publica. 2008 ; 82: 519-534
14. Cabrera de León A, Rodríguez Pérez MC, Rodríguez Benjumeda LM, et al. Sedentary lifestyle: physical activity duration versus percentage of energy expenditure. Rev Esp Cardiol. 2007 ; 60: 244-250
15. Cabrera de León A, Domínguez Coello S, Almeida González D, et al. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of diabetes in the Canary Islands. Diabet Med. 2012 ; 29: 399-403
16. Cabrera de León A, Rodríguez-Pérez MC, del Castillo-Rodríguez JC, et al. Coronary risk in the population of the Canary Islands, Spain, using the Framingham function. Med Clin. 2006 ; 126: 521-526
17. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program (Letter). Diabetes Care. 1998 ; 21: 2191-2192
18. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modelling. Diabetes Care. 2004 ; 27: 1487-1495
19. Katz P, Leiter LA, Mellbin L, et al. The clinical burden of type 2 diabetes in patients with acute coronary syndromes: prognosis and implications for short- and long-term management. Diab Vasc Dis Res. 2014 ; 11: 395-409
20. Barrett-Connor E, Wingard DL. 'Normal' blood glucose and coronary risk. BMJ. 2001 ; 322: 5-6
21. Cho M, Park JS, Nam J, et al. Association of abdominal obesity with atherosclerosis in type 2 diabetes mellitus (T2DM) in Korea. J Korean Med Sci. 2008 ; 23: 781-788
22. Abdullah A, Hasan H, Raigangar V, et al. C-Peptide versus insulin: relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young Arab females. Int J Endocrinol. 2012 ; 2012: 420792
23. Orchard TJ, Eichner J, Kuller LH, et al. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol. 1994 ; 4: 40-45
24. Robins SJ, Rubins HB, Faas FH, et al. Veterans Affairs HDL Intervention Trial (VA-HIT). Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care. 2003 ; 26: 1513-1517
25. Hills CE, Brunskill NJ. Intracellular signalling by C-peptide. Exp Diabetes Res. 2008 ; 2008: 635158
26. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006 ; 113: 1888-1904
27. Patel N, Taveira TH, Choudhary G, et al. Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc. 2012 ; 1: e003152
28. Min JY, Min KB. Serum C-peptide levels and risk of death among adults without diabetes mellitus. CMAJ. 2013 ; 185: E402 - E408